{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-001436","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.323728+00:00","generated_at":"2026-06-19T22:37:21.025038+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Pharma-Bio Serv retains ACP Capital Markets for M&A advisory and investment banking","bullets":["Retained ACP Capital Markets LLC for investment banking and M&A advisory services.","CEO Victor Sanchez says ACP will assist in strategic growth through potential acquisitions.","ACP’s M&A and Advisory practice is globally focused; securities placements via Aldwych Securities LLC.","Engagement aims to explore alternatives to maximize shareholder value and expand service portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-001436","json":"https://secwatch.observer/filing/0001654954-23-001436.json","markdown":"https://secwatch.observer/filing/0001654954-23-001436.md","text":"https://secwatch.observer/filing/0001654954-23-001436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423001436/0001654954-23-001436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423001436/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T22:37:21.025038+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}